miR-34a Enhances the Susceptibility of Gastric Cancer to Platycodin D by Targeting Survivin

Abstract

miR-34a could modulate the susceptibility of GC to PD via targeting survivin, suggesting miR-34a overexpression may serve as a novel strategy to sensitize GC to anti-cancer drugs.